Literature DB >> 1347454

Classification of vasculitis.

B A Michel1.   

Abstract

Usually classifications of vasculitic syndromes are based on clinical and histopathologic findings because pathogenetic mechanisms are poorly understood. A subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology recently developed classification criteria for seven major vasculitic disorders through the analysis of prospectively collected patient data from 48 centers. Using two classification methods, the subcommittee derived criteria for polyareritis nodosa, Churg-Strauss syndrome, Wegner's granulomatosis, hypersensitivity vasculitis, Henoch-Schönlein purpura, giant cell (temporal) arteritis, and Takayasu's arteritis. Although such criteria may identify typical patients with a distinct form of vasculitis, they are not intended to establish a diagnosis in an individual patient; rather, they should aid comparability of different patient groups in various research endeavors.

Entities:  

Mesh:

Year:  1992        PMID: 1347454

Source DB:  PubMed          Journal:  Curr Opin Rheumatol        ISSN: 1040-8711            Impact factor:   5.006


  3 in total

Review 1.  Cutaneous manifestations in systemic vasculitis.

Authors:  I Decleva; A V Marzano; M Barbareschi; E Berti
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 2.  Eosinophilic coronary periarteritis (vasospastic angina and sudden death), a new type of coronary arteritis: report of seven autopsy cases and a review of the literature.

Authors:  Hiroki Kajihara; Yoshiro Tachiyama; Takanori Hirose; Aya Takada; Aya Takata; Kazuyuki Saito; Tatsuya Murai; Wataru Yasui
Journal:  Virchows Arch       Date:  2012-12-12       Impact factor: 4.064

3.  Primary vasculitis in a Norwegian community hospital: a retrospective study.

Authors:  G Haugeberg; R Bie; A Bendvold; A S Larsen; V Johnsen
Journal:  Clin Rheumatol       Date:  1998       Impact factor: 2.980

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.